Merck & Co., Inc. (MRK) Tops Q3 EPS by 5c; Narrows FY13 EPS Outlook

October 28, 2013 7:01 AM EDT
Merck & Co., Inc. (NYSE: MRK) reported Q3 EPS of $0.92, $0.05 better than the analyst estimate of $0.87. Revenue for the quarter came in at $11.03 billion versus the consensus estimate of $11.19 billion.

Sees FY2013 EPS of $3.48-$3.52, versus the consensus of $3.47.

For earnings history and earnings-related data on Merck & Co., Inc. (MRK) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance

Related Entities